Acute decompensated heart failure (including cardiogenic shock)
Management of cardiogenic shock usually requires interventions to improve cardiac function (e.g., inotropic medications, revascularization, or a mechanical support). Cardiogenic shock patients may look deceptively OK, but they are indeed critically ill. Early recognition facilitates appropriate ICU management.
Cardiogenic Shock | Circulation - AHA/ASA Journals
2008年2月5日 · Cardiogenic shock (CS) occurs in ≈5% to 8% of patients hospitalized with ST-elevation myocardial infarction (STEMI). Recent research has suggested that the peripheral vasculature and neurohormonal and cytokine systems play a role in the pathogenesis and persistence of CS. Early revascularization for CS improves survival substantially.
23. Cardiogenic Shock | Hospital Handbook - UCSF Hospitalist …
3) Initiate therapies: it is crucial to interpret the CI and SVR before starting therapy. The diagnosis of cardiogenic shock should be made with a low CI and high SVR. A. Inotrope initiation. Goal: lactate clearance and ideally CI >2. Ensure norepinephrine is running/available to address potential vasodilatory response.
Cardiogenic Shock - StatPearls - NCBI Bookshelf
2023年4月7日 · Cardiogenic shock is a primary cardiac disorder characterized by a low cardiac output state of circulatory failure that results in end-organ hypoperfusion and tissue hypoxia. This activity reviews the evaluation and management of cardiogenic shock and explains the role of the interprofessional team in improving care for patients with this ...
Physiology, Peripheral Vascular Resistance - StatPearls - NCBI Bookshelf
2023年5月1日 · Cardiogenic shock is from a malfunction of the heart which results in decreased cardiac output and increased SVR. Neurogenic shock is from alterations in the autonomic nervous system that also results in decreased cardiac output and a decrease in SVR from a loss of the sympathetic innervation.
Pathophysiologic Vasodilation in Cardiogenic Shock and Its …
2024年7月25日 · Vasodilation was defined by lower systemic vascular resistance (SVR), higher norepinephrine equivalent dose, or a blunted SVR response to pressors. Threshold SVR values were determined by their relation to 14-day mortality in spline models. The primary outcome was death within 14 days of CS onset in multivariable-adjusted Cox models.
Cardiogenic Shock | Journal of the American Heart Association
2019年4月5日 · The SHOCK (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock) and intra‐aortic balloon pump (IABP)‐SHOCK II trials used systolic blood pressure (SBP) measurements of <90 mm Hg for ≥30 minutes or use of pharmacological and/or mechanical support to maintain an SBP ≥90 mm Hg. 1, 3, 4 Evidence of end‐organ ...
Cardiogenic Shock - Cardiovascular - Medbullets Step 2/3
identify and treat the underlying cause (e.g., revascularization in the case of myocardial infarction-induced cardiogenic shock)
Cardiogenic Shock - SpringerLink
2023年12月2日 · Cardiogenic shock is a life-threatening state of end-organ hypoperfusion secondary to low cardiac output caused by underlying cardiac dysfunction. Cardiogenic shock is associated with significant in-hospital mortality despite advancing therapies.
Cardiogenic shock is a heterogeneous and often fatal condition of critically low cardiac output and hypoperfusion typically caused by myocardial infarction or decompensated cardiomyopathy. Cardiogenic shock manifests a spectrum of severity quantified by the SCAI Shock Clas-